These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9873734)

  • 1. Acceptor substrate-based selective inhibition of galactosyltransferases.
    Chung SJ; Takayama S; Wong CH
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3359-64. PubMed ID: 9873734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncharged nucleoside inhibitors of β-1,4-galactosyltransferase with activity in cells.
    Jiang J; Kanabar V; Padilla B; Man F; Pitchford SC; Page CP; Wagner GK
    Chem Commun (Camb); 2016 Mar; 52(20):3955-8. PubMed ID: 26882174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise syntheses of selective inhibitors against α-1,3-galactosyltransferase.
    Zhang GL; Zhang LH; Ye XS
    Org Biomol Chem; 2010 Nov; 8(22):5062-8. PubMed ID: 20820649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new concept for glycosyltransferase inhibitors: nonionic mimics of the nucleotide donor of the human blood group B galactosyltransferase.
    Schaefer K; Albers J; Sindhuwinata N; Peters T; Meyer B
    Chembiochem; 2012 Feb; 13(3):443-50. PubMed ID: 22223604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.
    Brockhausen I; Benn M; Bhat S; Marone S; Riley JG; Montoya-Peleaz P; Vlahakis JZ; Paulsen H; Schutzbach JS; Szarek WA
    Glycoconj J; 2006 Nov; 23(7-8):525-41. PubMed ID: 17006644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisubstrate analogues as glycosyltransferase inhibitors.
    Izumi M; Yuasa H; Hashimoto H
    Curr Top Med Chem; 2009; 9(1):87-105. PubMed ID: 19199998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 5'-glycyl derivatives of uridine as inhibitors of 1,4-β-galactosyltransferase.
    Paszkowska J; Kral K; Bieg T; Żaba K; Węgrzyk K; Jaśkowiak N; Molinaro A; Silipo A; Wandzik I
    Bioorg Chem; 2015 Feb; 58():18-25. PubMed ID: 25462623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of glycosyltransferases by bivalent imidazolium salts.
    Gao Y; Vlahakis JZ; Szarek WA; Brockhausen I
    Bioorg Med Chem; 2013 Mar; 21(5):1305-11. PubMed ID: 23375091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of new inhibitors of UDP-Galf transferase--a key enzyme in M. tuberculosis cell wall biosynthesis.
    Cren S; Gurcha SS; Blake AJ; Besra GS; Thomas NR
    Org Biomol Chem; 2004 Sep; 2(17):2418-20. PubMed ID: 15326520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonionic inhibitor with high specificity for the UDP-Gal donor binding site of human blood group B galactosyltransferase: design, synthesis, and characterization.
    Schaefer K; Sindhuwinata N; Hackl T; Kötzler MP; Niemeyer FC; Palcic MM; Peters T; Meyer B
    J Med Chem; 2013 Mar; 56(5):2150-4. PubMed ID: 23406460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and enzymatic evaluation of modified acceptors of recombinant blood group A and B glycosyltransferases.
    Mukherjee A; Palcic MM; Hindsgaul O
    Carbohydr Res; 2000 May; 326(1):1-21. PubMed ID: 16001502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments.
    Rademacher C; Landström J; Sindhuwinata N; Palcic MM; Widmalm G; Peters T
    Glycoconj J; 2010 Apr; 27(3):349-58. PubMed ID: 20217221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of glycosyltransferase inhibitors: pyridine as a pyrophosphate surrogate.
    Wang S; Cuesta-Seijo JA; Lafont D; Palcic MM; Vidal S
    Chemistry; 2013 Nov; 19(45):15346-57. PubMed ID: 24108680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment Growing to Design Optimized Inhibitors for Human Blood Group B Galactosyltransferase (GTB).
    Strecker C; Peters H; Hackl T; Peters T; Meyer B
    ChemMedChem; 2019 Jul; 14(14):1336-1342. PubMed ID: 31207161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Double-Modified Xyloside Analogues for Probing the β4GalT7 Active Site.
    Willén D; Bengtsson D; Clementson S; Tykesson E; Manner S; Ellervik U
    J Org Chem; 2018 Feb; 83(3):1259-1277. PubMed ID: 29282986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of galactosyltransferases by a novel class of donor analogues.
    Descroix K; Pesnot T; Yoshimura Y; Gehrke SS; Wakarchuk W; Palcic MM; Wagner GK
    J Med Chem; 2012 Mar; 55(5):2015-24. PubMed ID: 22356319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the substrate specificity of alpha1,3galactosyltransferase utilizing modified N-acetyllactosamine disaccharides.
    Stults CL; Macher BA; Bhatti R; Srivastava OP; Hindsgaul O
    Glycobiology; 1999 Jul; 9(7):661-8. PubMed ID: 10362835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of active site tryptophans in substrate binding and catalysis by alpha-1,3 galactosyltransferase.
    Zhang Y; Deshpande A; Xie Z; Natesh R; Acharya KR; Brew K
    Glycobiology; 2004 Dec; 14(12):1295-302. PubMed ID: 15229192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-deoxy-hexopyranosyl derivatives of uridine as donor substrate analogues for glycosyltransferases.
    Wandzik I; Bieg T; Czaplicka M
    Bioorg Chem; 2009 Dec; 37(6):211-6. PubMed ID: 19765794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-C-phosphonomethyl- and 1-C-difluorophosphonomethyl-1,4-imino-l-arabinitols as Galf transferase inhibitors: A comparison.
    Cocaud C; Zheng RB; Lowary TL; Poisson T; Pannecoucke X; Nicolas C; Martin OR
    Carbohydr Res; 2018 May; 461():45-50. PubMed ID: 29579477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.